Pacmilimab by CytomX Therapeutics for Uterine Cancer: Likelihood of Approval

Pacmilimab is under clinical development by CytomX Therapeutics and currently in Phase II for Uterine Cancer.

Source link
#Pacmilimab #CytomX #Therapeutics #Uterine #Cancer #Likelihood #Approval